SSTH stödjer den nordiska koagulationskongressen som i år hålls på Karolinska Universitetssjukhuset. All information finns på: www.nordcoag26.se

Program

Onsdag 16 september

09.00–12.00 Förkongresskurs i Knepiga trombotiska tillstånd – Julieta Bomfim & Per Öst

11.00–12.00 Årsmöte Nordic Hemophilia Council Eva Zetterberg, Skånes universitetssjukhus

12.30–13.15 Industrisponsrade minisessioner

13.30–13.45 Välkomst- och öppningsanförande – Maria Bruzelius

13.45–15.00 Liver Disorder – Haemostasis and Thrombosis

Guidelines on Portal Vein Thrombosis Virginia Hernandez-Gea, Barcelona

Novel haemostatic assays and biomarkers in patients with liver cirrhosis – Sanna Norén

Kasabach-Merritt Syndrome – a multidisciplinary patient case – Hans Hemmingsson, Marie Sund & Tatiana von Bahr Greenwood

15.30–16.45 Platelet Disorders and Treatment

An update on Glanzmann Thrombasthenia – Roger Schutgens, Utrecht

Platelet function testing by flow cytometry in clinical settings – possibilities and challenges – Sofia Ramström, Örebro

Improving diagnostic work-up of platelet function disorders – David Schmidt

17.00–19.00 Guidad posterpromenad och kongressmingel

Torsdag 17 september

09.00–10.15 Haemophilia and bleeding disorders in clinical practice

Novel haemophilia treatment options, the German experience – Christoph Königs, Frankfurt

FVIII-Mimetic Treatment in Acquired Haemophilia A, Karolinska insights  – Maria Bruzelius

Building psychological resilience in patients with chronic disease, Karl Björk

10.45–12.00 Haemophilia – Laboratory Insights

Evolution of the Chromogenic Coagulation Factor Assays – Niklas Bark

Assessing Haemostatic Function in Non-Factor Hemophilia Therapies – Peter Lenting, Paris

Estimating the Haemostatic Capacity in Patients with Emizicumab – Adrian Kimiaei

Clinical Outcomes of Emizicumab Monitoring at Karolinska – Tony Frisk

12.20–13.05 Industrisponsrade minisessioner

13:15 – 14:30 Thrombosis Over Time: Risk Factors, Acute Events and Residual Disease

New era of oestrogens, balancing benefit & thrombotic risk Kristina Gemzell Danielsson

PE as a cause of cardiac arrest and death: age and sex differences – Emma Bendz

Magnetic Resonance Direct Thrombus Imaging – Gargi Gautam

15:00 – 16:15 Complexity in Thrombosis: Life-Course Determinants and Clinical Practice

Health equity in childhood and cardiovascular disease – Per Svensson

Prosthetic heart valve thrombosis – Mika Skeppholm

Primary subclavian vein thrombosis – early catheter-directed thrombolysis followed by decompression of the thoracic outlet – Jonas Malmstedt

16:30 – 17:30 War, crises and haemostatic challenges

Blood preparedness in emergencies – Agneta Wikman

Pre-hospital blood for civilian trauma in conflicts – Johan von Schreeb

Challenges in blood transfusion when resources are limited – Märit Halmin

19.00 Kongressmiddag

Fredag 18 september

8.00-8.45 Industrisponsrade minisessioner

09.00–10.15 Cancer Associated Thrombosis – from mechanism to treatment

Mechanisms and treatment in Cancer Associated Thrombosis – Anna Falanga, Milano

Venous thromboembolism as the first sign of malignancy – Axel Rosell

Coagulopathy in childhood acute lymphoblastic leukemia – Lovisa Malmqvist

Neutrophil extracellular trap formation in myeloproliferative neoplasms – Ingrid Lundahl

10.45–12.00 Von Willebrand’s Disease

Linking Pathophysiology, Diagnostics, and Patient Management – Omid Seidizadeh, Milano

Insights from Approximately 300 von Willebrand Genetic Investigations – August Lundholm

Acquired von Willebrand’s Disease – Anna Ågren

12.00–12.30  Poster Award and Closing Remarks – Maria Bruzelius

 

Organisationskomitten, Susanna Ranta, Maria Bruzelius och Charlotte Gran